Ewha Med J.  2015 Jul;38(2):69-71. 10.12771/emj.2015.38.2.69.

Transfusion-free Management for the Severe Anemia Developed after Nephrectomy

• Lee M
• Hwang C
• Lee JH
• Kim SH
• Park HY
• Song YG

• KMID: 2052783
• DOI: http://doi.org/10.12771/emj.2015.38.2.69

Abstract

A 56-year-old woman with emphysematous pyelonephritis underwent an emergent left nephrectomy due to her religious creed. Postoperative hemoglobin level was decreased to 4.4 g/dL from preoperative value of 13.9 g/dL. The patient completely recovered without transfusion and was discharged on the 40th postoperative day without complication.

Keyword

Nephrectomy; Anemia; Transfusion free

MeSH Terms

Anemia*
Female
Humans
Middle Aged
Nephrectomy*
Pyelonephritis

Figure

• 

  Fig. 1 Computed tomography of abdomen-pelvis. It shows empysematous pyelonephritis (arrow).

• 

  Fig. 2 Changes in hematocrit (Hct) and hemoglobin (Hb) levels of a patient during preoperative (Preop) and postoperative period (POD, postoperative day).

Reference

1. Narlawar RS, Raut AA, Nagar A, Hira P, Hanchate V, Asrani A. Imaging features and guided drainage in emphysematous pyelonephritis: a study of 11 cases. Clin Radiol. 2004; 59:192–197.

2. Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M. Emphysematous pyelonephritis. J Urol. 1984; 131:203–208.

3. Pontin AR, Barnes RD. Current management of emphysematous pyelonephritis. Nat Rev Urol. 2009; 6:272–279.

4. Park BS, Lee SJ, Kim YW, Huh JS, Kim JI, Chang SG. Outcome of nephrectomy and kidney-preserving procedures for the treatment of emphysematous pyelonephritis. Scand J Urol Nephrol. 2006; 40:332–338.

5. Koh KB, Lam HS, Lee SH. Emphysematous pyelonephritis: drainage or nephrectomy? Br J Urol. 1993; 71:609–611.

6. Bodnaruk ZM, Wong CJ, Thomas MJ. Meeting the clinical challenge of care for Jehovah's Witnesses. Transfus Med Rev. 2004; 18:105–116.

7. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts: blood transfusion. N Engl J Med. 1999; 340:438–447.

8. Isbister JP, Shander A, Spahn DR, Erhard J, Farmer SL, Hofmann A. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev. 2011; 25:89–101.

9. Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet? Transfusion. 1997; 37:121–125.

10. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011; 378:1396–1407.

11. Goodnough LT, Shander A, Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion. 2003; 43:668–676.

12. Goodnough LT, Brittenham GM. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med. 1990; 115:28–35.

13. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood. 2000; 96:823–833.

14. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002; 42:812–818.